Nidal Al‐Huniti

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

Thi Huyen Tram Nguyen, Nicholas H. G. Holford, Nidal Al‐Huniti et al. · CPT Pharmacometrics & Systems Pharmacology · 2016 · 381 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,3-dihydro-2<i>H</i>-imidazo[4,5-<i>c</i>]quinolin-2-one)

Kurt G. Pike, Bernard Barlaam, Elaine Cadogan et al. · Journal of Medicinal Chemistry · 2018 · 116 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Radiation and PD-(L)1 treatment combinations: immune response and dose optimization via a predictive systems model

Yuri Kosinsky, Simon J. Dovedi, Kirill Peskov et al. · Journal for ImmunoTherapy of Cancer · 2018 · 111 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Multiple-Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects

Rajesh Krishna, AJ Bergman, Bo Jin et al. · Clinical Pharmacology & Therapeutics · 2008 · 100 citations

Life Sciences, Pharmacokinetics, Pharmacology +16

Hypercholesterolemia is a Potential Risk Factor for Asthma

Baha Al-Shawwa, Nidal Al‐Huniti, Gregory Titus et al. · Journal of Asthma · 2006 · 92 citations

Medicine, Pediatrics, Clinical Epidemiology +11